Long-term follow-up and prognostic factors in ovarian carcinoma. The radiumhemmet series 1958 to 1973

Björkholm E, E Björkholm, Pettersson F, F Pettersson, N Einhorn, Einhorn N, I Krebs, Krebs I, Nilsson B, B Nilsson, B Tjernberg, Tjernberg B
Acta radiologica. Oncology · 1982 · vol. 21(6) , pp. 413–9 · doi:10.3109/02841868209134321 · PMID:6305119
Observational OA: bronze public-domain-us
📄 Open PDF Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-24 ⓘ

This analysis of 2412 women with epithelial ovarian carcinoma treated between 1958 and 1973 found that advanced stage, high age, true malignancy, and specific histological types were associated with poor prognosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-02 · read from full text ⓘ

This study analyzed long-term outcomes for 2,412 women treated with epithelial ovarian carcinoma at Radiumhemmet between 1958 and 1973. The research identified that advanced stage, high age at diagnosis, true malignancy, and specific histological types such as serous or clear cell carcinomas were associated with poor prognosis. Conversely, patients with borderline malignancy tumors demonstrated a significantly higher five-year relative survival rate of 93 percent, even in advanced stages. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Between 1958 and 1973, 2412 women with epithelial ovarian carcinoma were treated at Radiumhemmet. Of these tumors, 14.5 per cent were of borderline malignancy. The 5-year relative survival rate was 34 per cent among the patients with true malignant tumor and 93 per cent in the borderline cases. Even in advanced stages (IIb-IV) the 5-year survival rate was 78 per cent in the borderline cases. Advanced stage and high age at diagnosis, true malignancy and tumors of serous, clear cell or anaplastic type were associated with poor prognosis. The 5-year relative survival rate of patients with epithelial ovarian carcinoma in an early stage improved during the period, from 67 to 81 per cent.
Full text 848 characters · extracted from oa-doi-fallback · click to expand
Long-Term Follow-Up and Prognostic Factors in Ovarian Carcinoma: The Radiumhemmet series 1958 to 1973 DOI: https://doi.org/10.3109/02841868209134321Abstract Between 1958 and 1973, 2412 women with epithelial ovarian carcinoma were treated at Radiumhemmet. Of these tumors, 14.5 per cent were of borderline malignancy. The 5-year relative survival rate was 34 per cent among the patients with true malignant tumor and 93 per cent in the borderline cases. Even in advanced stages (IIb-IV) the 5-year survival rate was 78 per cent in the borderline cases. Advanced stage and high age at diagnosis, true malignancy and tumors of serous, clear cell or anaplastic type were associated with poor prognosis. The 5-year relative survival rate of patients with epithelial ovarian carcinoma in an early stage improved during the period, from 67 to 81 per cent.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Adenocarcinoma Adenocarcinoma, Mucinous Carcinoma Ovarian Neoplasms Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma, Mucinous Adenocarcinoma, Mucinous Adenocarcinoma, Mucinous Carcinoma Carcinoma Carcinoma Endometriosis Endometriosis Endometriosis Endometriosis Female Female Follow-Up Studies

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-25T09:32:14.900964+00:00
pubmed
last seen: 2026-10-08T21:58:08.863946+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine